Ladenburg Thalmann Starts Furiex Pharmaceuticals (FURX) at Buy, Sets $30 Price Target
Tweet
Share
E-mailGet Alerts FURX Hot Sheet
Price: $104.77 --0%
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ladenburg Thalmann initiates coverage on shares of Furiex Pharmaceuticals (NASDAQ: FURX) with a Buy rating and $30 price target.
For an analyst ratings summary and ratings history on Furiex Pharmaceuticals click here. For more ratings news on Furiex Pharmaceuticals click here.
Shares of Furiex Pharmaceuticals closed at $19.88 yesterday.
For an analyst ratings summary and ratings history on Furiex Pharmaceuticals click here. For more ratings news on Furiex Pharmaceuticals click here.
Shares of Furiex Pharmaceuticals closed at $19.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies Starts Aditya Birla Real Estate (ABREL:IN) at Buy
- Jefferies Starts Freenome Inc. (FRNM) at Buy
- Citi Resumes Universal Music Group NV (UMG:NA) (UMGNF) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Ladenburg Thalmann Financial ServicesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
